Actively Recruiting

Phase Not Applicable
Age: 18Years - 50Years
MALE
ID05414045

Autologous Testicular Tissue Transplantation for Fertility Restoration

Led by Universitair Ziekenhuis Brussel · Updated on 2026-04-23

5

Participants Needed

1

Research Sites

13 weeks

Total Duration

On this page

Sponsors

U

Universitair Ziekenhuis Brussel

Lead Sponsor

V

Vrije Universiteit Brussel

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating autologous testicular tissue transplantation as a method to restore fertility in men who had their testicular tissue frozen as prepubertal boys due to cancer or hematological diseases. This approach is considered when no sperm suitable for intra-cytoplasmic sperm injection (ICSI) is found in the ejaculate despite cryopreservation efforts. The goal is to restore spermatogenesis and fertility by transplanting the preserved tissue back into the patient. The study involves transplanting autologous testicular tissue that was previously frozen during childhood. Men who return for transplantation will first undergo semen and blood analyses. If no usable sperm are found, the transplantation procedure will be performed. Graft removal and histological studies will occur 12 months after grafting. Participants will be followed up with imaging, hormonal, biomarker, and complication assessments at 3, 6, 9, 12, and 15 months post-grafting. Participants will be monitored closely for up to 15 months after transplantation to assess restoration of sperm production and overall fertility. Evaluations include semen analysis for sperm presence in the graft, imaging, hormonal studies, and biomarker assessments at specified intervals. Safety and potential complications will also be tracked. The study aims to provide important information on the feasibility and outcomes of this novel fertility restoration method.

CONDITIONS

Brief Title

Autologous Testicular Tissue Transplantation

Who Can Participate

Age: 18Years - 50Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Male patients who opted as prepubertal boys to enroll in the fertility preservation program
  • Age between 18 and 50 years old
  • Female partner younger than 43 years old
  • No spermatozoa suitable for intra-cytoplasmic sperm injection (ICSI) found on at least two semen analyses
  • Normal standardized preliminary and preoperative blood sampling results
  • Complete remission of the oncological or hematological disease
  • Approval from treating oncologist or relevant specialist for testicular tissue preservation
  • Negligible risk of malignant cells in testicular tissue based on multidisciplinary assessment
  • Presence of spermatogonial stem cells confirmed in thawed tissue fragments
  • Written informed consent for transplantation and follow-up, including consent for children born after procedure
Not Eligible

You will not qualify if you...

  • Risk of malignant cells present in the testicular tissue
  • Contraindication for surgery
  • Contraindication for pregnancy in the female partner
  • Body mass index (BMI) over 32
  • Heavy smoking (10 or more cigarettes per day)
  • Unstable psychological condition

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Graft removal is planned 12 months after transplantation

Participants receive autologous testicular tissue transplantation to restore spermatogenesis and fertility.

1 transplantation visit and graft removal visit at 12 months

Follow-up

Duration - Up to 15 months post-grafting

Participants are followed up to monitor graft function, hormonal levels, imaging, biomarkers, and complications after transplantation.

Visits at 3, 6, 9, 12, and 15 months post-transplantation

Trial Site Locations

Total: 1 location

1

UZ Brussel Centre for Reproductive Medicine

Brussels, Belgium, 1090

Actively Recruiting

Loading map...

Research Team

V

Veerle Vloeberghs, MD

H

Herman Tournaye, MD PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here